The impact of PKR activation: From neurodegeneration to cancer

FASEB Journal

Volumn 28, Issue 5, 2014, Pages 1965-1974

  Marchal, Juan A ^a,b   Lopez, Gabriel J ^c   Peran, Macarena ^a,d   Comino, Ana ^e   Delgado, Juan R ^e   García García, Javier A ^e   Conde, Veronica ^e   Aranda, Fernando M ^e   Rivas, Carmen ^f,g   Esteban, Mariano ^f   Garcia, Maria A ^e  

^a UNIVERSITY OF GRANADA   (Spain)

^b UNIVERSITY OF GRANADA   (Spain)

^c Servicio de Cirugía Complejo Hospitalario Torrecárdenas   (Spain)

^d UNIVERSITY OF JAÉN   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

^f CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^g UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Apoptosis; Protein kinase R; Protein kinase R modulators

Indexed keywords

GUANINE NUCLEOTIDE EXCHANGE FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INITIATION FACTOR 2ALPHA; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; METHIONYL AMINOPEPTIDASE 2; MICRORNA; PACT PROTEIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN; PROTEIN KINASE R; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; BRAIN; CANCER GROWTH; CANCER PREVENTION; CANCER PROGNOSIS; CARCINOGENESIS; CELL DEATH; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CELL STRESS; CLINICAL STUDY; CORRELATIONAL STUDY; DEGENERATIVE DISEASE; DISEASE ASSOCIATION; GENE EXPRESSION; HUMAN; IMMUNOMODULATION; INFLAMMATION; INFLAMMATORY DISEASE; NEOPLASM; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STRESS; TUMOR SUPPRESSOR GENE;

APOPTOSIS; PROTEIN KINASE R; PROTEIN KINASE R MODULATORS;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; DISEASE PROGRESSION; EIF-2 KINASE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INFLAMMATION; MICRORNAS; NEOPLASMS; NEURODEGENERATIVE DISEASES; NF-KAPPA B; PHOSPHORYLATION; PROGNOSIS; PROTEIN PROCESSING, POST-TRANSLATIONAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84901045220     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.13-248294     Document Type: Review

References (137)

1. Driver, J. A., Beiser, A., Au, R., Kreger, B. E., Splansky, G. L., Kurth, T., Kiel, D. P., Lu, K. P., Seshadri, S., and Wolf, P. A. (2012) Inverse association between cancer and Alzheimer's disease: results from the Framingham Heart Study. BMJ 344, e1442
2. Roe, C. M., Fitzpatrick, A. L., Xiong, C., Sieh, W., Kuller, L., Miller, J. P., Williams, M. M., Kopan, R., Behrens, M. I., and Morris, J. C. (2010) Cancer linked to Alzheimer disease but not vascular dementia. Neurology 74, 106-112
3. Thinnes, F. P. (2012) Alzheimer disease controls cancer: concerning the apoptogenic interaction of cell membranestanding type-1 VDAC and amyloid peptides via GxxxG motifs. Mol. Genet. Metab. 106, 502-503
4. Pindel, A., and Sadler, A. (2011) The role of protein kinase R in the interferon response. J. Interferon Cytokine Res. 31, 59-70
5. Garcia, M. A., Gil, J., Ventoso, I., Guerra, S., Domingo, E., Rivas, C., and Esteban, M. (2006) Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol. Mol. Biol. Rev. 70, 1032-1060
6. Williams, B. R. (2001) Signal integration via PKR. Sci. STKE 2001, re2
7. Donnelly, N., Gorman, A. M., Gupta, S., and Samali, A. (2013) The eIF2alpha kinases: their structures and functions. Cell. Mol. Life Sci. 70, 3493-3511
8. Williams, B. R. (1999) PKR: a sentinel kinase for cellular stress. Oncogene 18, 6112-6120
9. Patel, S., Blose, J. M., Sokoloski, J. E., Pollack, L., and Bevilacqua, P. C. (2012) Specificity of the double-stranded RNAbinding domain from the RNA-activated protein kinase PKR for double-stranded RNA: insights from thermodynamics and small-angle X-ray scattering. Biochemistry 51, 9312-9322
10. Morel, M., Couturier, J., Lafay-Chebassier, C., Paccalin, M., and Page, G. (2009) PKR, the double stranded RNA-dependent protein kinase as a critical target in Alzheimer's disease. J. Cell. Mol. Med. 13, 1476-1488
11. Marques, J. T., White, C. L., Peters, G. A., Williams, B. R., and Sen, G. C. (2008) The role of PACT in mediating gene induction, PKR activation, and apoptosis in response to diverse stimuli. J. Interferon Cytokine Res. 28, 469-476
12. Singh, M., and Patel, R. C. (2012) Increased interaction between PACT molecules in response to stress signals is required for PKR activation. J. Cell. Biochem. 113, 2754-2764
13. Carvalho-Filho, M. A., Carvalho, B. M., Oliveira, A. G., Guadagnini, D., Ueno, M., Dias, M. M., Tsukumo, D. M., Hirabara, S. M., Reis, L. F., Curi, R., Carvalheira, J. B., and Saad, M. J. (2012) Double-stranded RNA-activated protein kinase is a key modulator of insulin sensitivity in physiological conditions and in obesity in mice. Endocrinology 153, 5261-5274
14. Carvalho, B. M., Oliveira, A. G., Ueno, M., Araujo, T. G., Guadagnini, D., Carvalho-Filho, M. A., Geloneze, B., Lima, M. M., Pareja, J. C., Carvalheira, J. B., and Saad, M. J. (2013) Modulation of double-stranded RNA-activated protein kinase in insulin sensitive tissues of obese humans. Obesity (Silver Spring) 21, 2452-2457
15. Gil, J., Alcami, J., and Esteban, M. (2000) Activation of NF-kappa B by the dsRNA-dependent protein kinase, PKR involves the I kappa B kinase complex. Oncogene 19, 1369-1378
16. Gil, J., Garcia, M. A., Gomez-Puertas, P., Guerra, S., Rullas, J., Nakano, H., Alcami, J., and Esteban, M. (2004) TRAF family proteins link PKR with NF-kappa B activation. Mol. Cell. Biol. 24, 4502-4512
17. Yoon, C. H., Lee, E. S., Lim, D. S., and Bae, Y. S. (2009) PKR, a p53 target gene, plays a crucial role in the tumor-suppressor function of p53. Proc. Natl. Acad. Sci. U. S. A. 106, 7852-7857
18. Ruuska, M., Sahlberg, A. S., Colbert, R. A., Granfors, K., and Penttinen, M. A. (2012) Enhanced phosphorylation of STAT-1 is dependent on double-stranded RNA-dependent protein kinase signaling in HLA-B27-expressing U937 monocytic cells. Arthritis Rheum. 64, 772-777
19. Xu, M., Chen, G., Wang, S., Liao, M., Frank, J. A., Bower, K. A., Zhang, Z., Shi, X., and Luo, J. (2012) Double-stranded RNAdependent protein kinase regulates the motility of breast cancer cells. PLoS ONE 7, e47721
20. Chang, R. C., Suen, K. C., Ma, C. H., Elyaman, W., Ng, H. K., and Hugon, J. (2002) Involvement of double-stranded RNAdependent protein kinase and phosphorylation of eukaryotic initiation factor-2alpha in neuronal degeneration. J. Neurochem. 83, 1215-1225
21. Suen, K. C., Yu, M. S., So, K. F., Chang, R. C., and Hugon, J. (2003) Upstream signaling pathways leading to the activation of double-stranded RNA-dependent serine/threonine protein kinase in beta-amyloid peptide neurotoxicity. J. Biol. Chem. 278, 49819-49827
22. Onuki, R., Bando, Y., Suyama, E., Katayama, T., Kawasaki, H., Baba, T., Tohyama, M., and Taira, K. (2004) An RNA-dependent protein kinase is involved in tunicamycin-induced apoptosis and Alzheimer's disease. EMBO J. 23, 959-968
23. Peel, A. L., Rao, R. V., Cottrell, B. A., Hayden, M. R., Ellerby, L. M., and Bredesen, D. E. (2001) Double-stranded RNAdependent protein kinase, PKR, binds preferentially to Huntington's disease (HD) transcripts and is activated in HD tissue. Hum. Mol. Genet. 10, 1531-1538
24. Bando, Y., Onuki, R., Katayama, T., Manabe, T., Kudo, T., Taira, K., and Tohyama, M. (2005) Double-strand RNA dependent protein kinase (PKR) is involved in the extrastriatal degeneration in Parkinson's disease and Huntington's disease. Neurochem. Int. 46, 11-18
25. Peel, A. L. (2004) PKR activation in neurodegenerative disease. J Neuropathol. Exp. Neurol. 63, 97-105
26. Barbosa, C., Peixeiro, I., and Romao, L. (2013) Gene expression regulation by upstream open reading frames and human disease. PLoS Genet. 9, e1003529
27. Mouton-Liger, F., Paquet, C., Dumurgier, J., Bouras, C., Pradier, L., Gray, F., and Hugon, J. (2012) Oxidative stress increases BACE1 protein levels through activation of the PKR-eIF2alpha pathway. Biochim. Biophys. Acta 1822, 885-896
28. Bose, A., Mouton-Liger, F., Paquet, C., Mazot, P., Vigny, M., Gray, F., and Hugon, J. (2011) Modulation of tau phosphorylation by the kinase PKR: implications in Alzheimer's disease. Brain Pathol. 21, 189-200
29. Couturier, J., Paccalin, M., Morel, M., Terro, F., Milin, S., Pontcharraud, R., Fauconneau, B., and Page, G. (2011) Prevention of the beta-amyloid peptide-induced inflammatory process by inhibition of double-stranded RNA-dependent protein kinase in primary murine mixed co-cultures. J. Neuroinflammation 8, 72
30. Couturier, J., Paccalin, M., Lafay-Chebassier, C., Chalon, S., Ingrand, I., Pinguet, J., Pontcharraud, R., Guillard, O., Fauconneau, B., and Page, G. (2012) Pharmacological inhibition of PKR in APPswePS1dE9 mice transiently prevents inflammation at 12 months of age but increases Abeta42 levels in the late stages of the Alzheimer's disease. Curr. Alzheimer Res. 9, 344-360
31. Page, G., Rioux Bilan, A., Ingrand, S., Lafay-Chebassier, C., Pain, S., Perault Pochat, M. C., Bouras, C., Bayer, T., and Hugon, J. (2006) Activated double-stranded RNA-dependent protein kinase and neuronal death in models of Alzheimer's disease. Neuroscience 139, 1343-1354
32. Hugon, J., Paquet, C., and Chang, R. C. (2009) Could PKR inhibition modulate human neurodegeneration? Expert Rev. Neurother. 9, 1455-1457
33. Zhu, P. J., Huang, W., Kalikulov, D., Yoo, J. W., Placzek, A. N., Stoica, L., Zhou, H., Bell, J. C., Friedlander, M. J., Krnjevic, K., Noebels, J. L., and Costa-Mattioli, M. (2011) Suppression of PKR promotes network excitability and enhanced cognition by interferon-gamma-mediated disinhibition. Cell 147, 1384-1396
34. Stern, E., Chinnakkaruppan, A., David, O., Sonenberg, N., and Rosenblum, K. (2013) Blocking the eIF2alpha kinase (PKR) enhances positive and negative forms of cortex-dependent taste memory. J. Neurosci. 33, 2517-2525
35. Joshi, M., Kulkarni, A., and Pal, J. K. (2013) Small molecule modulators of eukaryotic initiation factor 2alpha kinases, the key regulators of protein synthesis. Biochimie 95, 1980-1990
36. Chen, H. M., Wang, L., and D'Mello, S. R. (2008) A chemical compound commonly used to inhibit PKR, {8-(imidazol-4-ylmethylene)-6H-azolidino[5,4-g] benzothiazol-7-one}, protects neurons by inhibiting cyclin-dependent kinase. Eur. J. Neurosci. 28, 2003-2016
37. Nag, S., Qin, J., Srivenugopal, K. S., Wang, M., and Zhang, R. (2013) The MDM2-p53 pathway revisited. J. Biomed. Res. 27, 254-271
38. Lanni, C., Racchi, M., Memo, M., Govoni, S., and Uberti, D. (2012) p53 at the crossroads between cancer and neurodegeneration. Free Radic. Biol. Med. 52, 1727-1733
39. Sunico, C. R., Nakamura, T., Rockenstein, E., Mante, M., Adame, A., Chan, S. F., Newmeyer, T. F., Masliah, E., Nakanishi, N., and Lipton, S. A. (2013) S-Nitrosylation of parkin as a novel regulator of p53-mediated neuronal cell death in sporadic Parkinson's disease. Mol. Neurodegener. 8, 29
40. Buizza, L., Prandelli, C., Bonini, S. A., Delbarba, A., Cenini, G., Lanni, C., Buoso, E., Racchi, M., Govoni, S., Memo, M., and Uberti, D. (2013) Conformational altered p53 affects neuronal function: relevance for the response to toxic insult and growthassociated protein 43 expression. Cell Death Dis. 4, e484
41. Lee, J. E., Kang, J. S., Shin, I. C., Lee, S. J., Hyun, D. H., Lee, K. S., and Koh, H. C. (2011) Fluazinam-induced apoptosis of SH-SY5Y cells is mediated by p53 and Bcl-2 family proteins. Neurotoxicology 32, 702-710
42. Kotipatruni, R. R., Dasari, V. R., Veeravalli, K. K., Dinh, D. H., Fassett, D., and Rao, J. S. (2011) p53- and Bax-mediated apoptosis in injured rat spinal cord. Neurochem. Res. 36, 2063-2074
43. Hong, L. Z., Zhao, X. Y., and Zhang, H. L. (2010) p53-mediated neuronal cell death in ischemic brain injury. Neurosci. Bull. 26, 232-240
44. Fujiwara, T., and Morimoto, K. (2012) Inhibition of p53 transactivation functionally interacts with microtubule stabilization to suppress excitotoxicity-induced axon degeneration. Biochem. Biophys. Res. Commun. 427, 100-106
45. Thotala, D. K., Hallahan, D. E., and Yazlovitskaya, E. M. (2012) Glycogen synthase kinase 3beta inhibitors protect hippocampal neurons from radiation-induced apoptosis by regulating MDM2-p53 pathway. Cell Death Differ. 19, 387-396
46. Sendoel, A., Kohler, I., Fellmann, C., Lowe, S. W., and Hengartner, M. O. (2010) HIF-1 antagonizes p53-mediated apoptosis through a secreted neuronal tyrosinase. Nature 465, 577-583
47. Uo, T., Veenstra, T. D., and Morrison, R. S. (2009) Histone deacetylase inhibitors prevent p53-dependent and p53-independent Bax-mediated neuronal apoptosis through two distinct mechanisms. J. Neurosci. 29, 2824-2832
48. Gaub, P., Tedeschi, A., Puttagunta, R., Nguyen, T., Schmandke, A., and Di Giovanni, S. (2010) HDAC inhibition promotes neuronal outgrowth and counteracts growth cone collapse through CBP/p300 and P/CAF-dependent p53 acetylation. Cell Death Differ. 17, 1392-1408
49. Brochier, C., Dennis, G., Rivieccio, M. A., McLaughlin, K., Coppola, G., Ratan, R. R., and Langley, B. (2013) Specific acetylation of p53 by HDAC inhibition prevents DNA damageinduced apoptosis in neurons. J. Neurosci. 33, 8621-8632
50. Liu, Y., Chen, Y., Lu, X., Wang, Y., Duan, Y., Cheng, C., and Shen, A. (2012) SCYL1BP1 modulates neurite outgrowth and regeneration by regulating the Mdm2/p53 pathway. Mol. Biol. Cell 23, 4506-4514
51. Lanni, C., Racchi, M., Stanga, S., Mazzini, G., Ranzenigo, A., Polotti, R., Memo, M., Govoni, S., and Uberti, D. (2010) Unfolded p53 in blood as a predictive signature signature of the transition from mild cognitive impairment to Alzheimer's disease. J. Alzheimers Dis. 20, 97-104
52. Zhou, X., and Jia, J. (2010) P53-mediated G(1)/S checkpoint dysfunction in lymphocytes from Alzheimer's disease patients. Neurosci. Lett. 468, 320-325
53. Serrano, J., Fernandez, A. P., Martinez-Murillo, R., and Martinez, A. (2010) High sensitivity to carcinogens in the brain of a mouse model of Alzheimer's disease. Oncogene 29, 2165-2171
54. Stanga, S., Lanni, C., Sinforiani, E., Mazzini, G., and Racchi, M. (2012) Searching for predictive blood biomarkers: misfolded p53 in mild cognitive impairment. Curr. Alzheimer Res. 9, 1191-1197
55. Tan, M., Wang, S., Song, J., and Jia, J. (2012) Combination of p53(ser15) and p21/p21(thr145) in peripheral blood lymphocytes as potential Alzheimer's disease biomarkers. Neurosci. Lett. 516, 226-231
56. Cuddihy, A. R., Wong, A. H., Tam, N. W., Li, S., and Koromilas, A. E. (1999) The double-stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitro. Oncogene 18, 2690-2702
57. Raven, J. F., Baltzis, D., Wang, S., Mounir, Z., Papadakis, A. I., Gao, H. Q., and Koromilas, A. E. (2008) PKR and PKR-like endoplasmic reticulum kinase induce the proteasome-dependent degradation of cyclin D1 via a mechanism requiring eukaryotic initiation factor 2alpha phosphorylation. J. Biol. Chem. 283, 3097-3108
58. Damjanac, M., Page, G., Ragot, S., Laborie, G., Gil, R., Hugon, J., and Paccalin, M. (2009) PKR, a cognitive decline biomarker, can regulate translation via two consecutive molecular targets p53 and Redd1 in lymphocytes of AD patients. J. Cell. Mol. Med. 13, 1823-1832
59. Morel, M., Couturier, J., Pontcharraud, R., Gil, R., Fauconneau, B., Paccalin, M., and Page, G. (2009) Evidence of molecular links between PKR and mTOR signalling pathways in Abeta neurotoxicity: role of p53, Redd1 and TSC2. Neurobiol. Dis. 36, 151-161
60. Mounir, Z., and Koromilas, A. E. (2010) Uncovering the PKR pathway's potential for treatment of tumors. Future Oncol. 6, 643-645
61. Savinova, O., Joshi, B., and Jagus, R. (1999) Abnormal levels and minimal activity of the dsRNA-activated protein kinase, PKR, in breast carcinoma cells. Int. J. Biochem. Cell Biol. 31, 175-189
62. Chong, K. L., Feng, L., Schappert, K., Meurs, E., Donahue, T. F., Friesen, J. D., Hovanessian, A. G., and Williams, B. R. (1992) Human p68 kinase exhibits growth suppression in yeast and homology to the translational regulator GCN2. EMBO J. 11, 1553-1562
63. Meurs, E. F., Galabru, J., Barber, G. N., Katze, M. G., and Hovanessian, A. G. (1993) Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase. Proc. Natl. Acad. Sci. U. S. A. 90, 232-236
64. Koromilas, A. E., Roy, S., Barber, G. N., Katze, M. G., and Sonenberg, N. (1992) Malignant transformation by a mutant of the IFN-inducible dsRNA-dependent protein kinase. Science 257, 1685-1689
65. Barber, G. N., Jagus, R., Meurs, E. F., Hovanessian, A. G., and Katze, M. G. (1995) Molecular mechanisms responsible for malignant transformation by regulatory and catalytic domain variants of the interferon-induced enzyme RNA-dependent protein kinase. J. Biol. Chem. 270, 17423-17428
66. Gil, J., Garcia, M. A., and Esteban, M. (2002) Caspase 9 activation by the dsRNA-dependent protein kinase, PKR: molecular mechanism and relevance. FEBS Lett. 529, 249-255
67. Garcia, M. A., Carrasco, E., Aguilera, M., Alvarez, P., Rivas, C., Campos, J. M., Prados, J. C., Calleja, M. A., Esteban, M., Marchal, J. A., and Aranega, A. (2011) The chemotherapeutic drug 5-fluorouracil promotes PKR-mediated apoptosis in a p53-independent manner in colon and breast cancer cells. PLoS ONE 6, e23887
68. Mounir, Z., Krishnamoorthy, J. L., Robertson, G. P., Scheuner, D., Kaufman, R. J., Georgescu, M. M., and Koromilas, A. E. (2009) Tumor suppression by PTEN requires the activation of the PKR-eIF2alpha phosphorylation pathway. Sci. Signal. 2, ra85
69. Lobo, M. V., Martin, M. E., Perez, M. I., Alonso, F. J., Redondo, C., Alvarez, M. I., and Salinas, M. (2000) Levels, phosphorylation status and cellular localization of translational factor eIF2 in gastrointestinal carcinomas. Histochem. J. 32, 139-150
70. Rosenwald, I. B. (2004) The role of translation in neoplastic transformation from a pathologist's point of view. Oncogene 23, 3230-3247
71. Guo, C., Shao, R., Correa, A. M., Behrens, C., Johnson, F. M., Raso, M. G., Prudkin, L., Solis, L. M., Nunez, M. I., Fang, B., Roth, J. A., Wistuba, II, Swisher, S. G., Lin, T., and Pataer, A. (2013) Prognostic significance of combinations of RNA-dependent protein kinase and EphA2 biomarkers for NSCLC. J. Thorac. Oncol. 8, 301-308
72. He, Y., Correa, A. M., Raso, M. G., Hofstetter, W. L., Fang, B., Behrens, C., Roth, J. A., Zhou, Y., Yu, L., Wistuba, I. I., Swisher, S. G., and Pataer, A. (2011) The role of PKR/eIF2alpha signaling pathway in prognosis of non-small cell lung cancer. PLoS ONE 6, e24855
73. Pataer, A., Raso, M. G., Correa, A. M., Behrens, C., Tsuta, K., Solis, L., Fang, B., Roth, J. A., Wistuba, I. I., and Swisher, S. G. (2010) Prognostic significance of RNA-dependent protein kinase on non-small cell lung cancer patients. Clin. Cancer Res. 16, 5522-5528
74. Kwon, H. C., Moon, C. H., Kim, S. H., Choi, H. J., Lee, H. S., Roh, M. S., Hwang, T. H., Kim, J. S., and Kim, H. J. (2005) Expression of double-stranded RNA-activated protein kinase (PKR) and its prognostic significance in lymph node negative rectal cancer. Jpn. J. Clin. Oncol. 35, 545-550
75. Hii, S. I., Hardy, L., Crough, T., Payne, E. J., Grimmett, K., Gill, D., and McMillan, N. A. (2004) Loss of PKR activity in chronic lymphocytic leukemia. Int. J. Cancer 109, 329-335
76. Shimada, A., Shiota, G., Miyata, H., Kamahora, T., Kawasaki, H., Shiraki, K., Hino, S., and Terada, T. (1998) Aberrant expression of double-stranded RNA-dependent protein kinase in hepatocytes of chronic hepatitis and differentiated hepatocellular carcinoma. Cancer Res. 58, 4434-4438
77. Blalock, W. L., Bavelloni, A., Piazzi, M., Faenza, I., and Cocco, L. (2010) A role for PKR in hematologic malignancies. J. Cell. Physiol. 223, 572-591
78. Cheng, X., Bennett, R. L., Liu, X., Byrne, M., and Stratford May, W. (2013) PKR negatively regulates leukemia progression in association with PP2A activation, Bcl-2 inhibition and increased apoptosis. Blood Cancer J. 3, e144
79. Liu, X., Bennett, R. L., Cheng, X., Byrne, M., Reinhard, M. K., and May, W. S., Jr. (2013) PKR regulates proliferation, differentiation, and survival of murine hematopoietic stem/progenitor cells. Blood 121, 3364-3374
80. Peidis, P., Papadakis, A. I., Muaddi, H., Richard, S., and Koromilas, A. E. (2011) Doxorubicin bypasses the cytoprotective effects of eIF2alpha phosphorylation and promotes PKRmediated cell death. Cell Death Differ. 18, 145-154
81. Bennett, R. L., Carruthers, A. L., Hui, T., Kerney, K. R., Liu, X., and May, W. S., Jr. (2012) Increased expression of the dsRNAactivated protein kinase PKR in breast cancer promotes sensitivity to doxorubicin. PLoS ONE 7, e46040
82. Marchal, J. A., Carrasco, E., Ramirez, A., Jimenez, G., Olmedo, C., Peran, M., Agil, A., Conejo-Garcia, A., Cruz-Lopez, O., Campos, J. M., and Garcia, M. A. (2013) Bozepinib, a novel small antitumor agent, induces PKR-mediated apoptosis and synergizes with IFNalpha triggering apoptosis, autophagy and senescence. Drug Des. Devel. Ther. 7, 1301-1313
83. Terada, T., Ueyama, J., Ukita, Y., and Ohta, T. (2000) Protein expression of double-stranded RNA-activated protein kinase (PKR) in intrahepatic bile ducts in normal adult livers, fetal livers, primary biliary cirrhosis, hepatolithiasis and intrahepatic cholangiocarcinoma. Liver 20, 450-457
84. Terada, T., Maeta, H., Endo, K., and Ohta, T. (2000) Protein expression of double-stranded RNA-activated protein kinase in thyroid carcinomas: correlations with histologic types, pathologic parameters, and Ki-67 labeling. Hum. Pathol. 31, 817-821
85. Hiasa, Y., Kamegaya, Y., Nuriya, H., Onji, M., Kohara, M., Schmidt, E. V., and Chung, R. T. (2003) Protein kinase R is increased and is functional in hepatitis C virus-related hepatocellular carcinoma. Am. J. Gastroenterol. 98, 2528-2534
86. Kim, S. H., Gunnery, S., Choe, J. K., and Mathews, M. B. (2002) Neoplastic progression in melanoma and colon cancer is associated with increased expression and activity of the interferon-inducible protein kinase, PKR. Oncogene 21, 8741-8748
87. Haines, G. K., Cajulis, R., Hayden, R., Duda, R., Talamonti, M., and Radosevich, J. A. (1996) Expression of the doublestranded RNA-dependent protein kinase (p68) in human breast tissues. Tumour Biol. 17, 5-12
88. Roh, M. S., Kwak, J. Y., Kim, S. J., Lee, H. W., Kwon, H. C., Hwang, T. H., Choi, P. J., and Hong, Y. S. (2005) Expression of double-stranded RNA-activated protein kinase in small-size peripheral adenocarcinoma of the lung. Pathol. Int. 55, 688-693
89. Prasad, S., Ravindran, J., and Aggarwal, B. B. (2010) NFkappaB and cancer: how intimate is this relationship. Mol. Cell. Biochem. 336, 25-37
90. Delgado Andre, N., and De Lucca, F. L. (2007) Knockdown of PKR expression by RNAi reduces pulmonary metastatic potential of B16-F10 melanoma cells in mice: possible role of NF-kappaB. Cancer Lett. 258, 118-125
91. Kunkeaw, N., Jeon, S. H., Lee, K., Johnson, B. H., Tanasanvimon, S., Javle, M., Pairojkul, C., Chamgramol, Y., Wongfieng, W., Gong, B., Leelayuwat, C., and Lee, Y. S. (2012) Cell death/proliferation roles for nc886, a non-coding RNA, in the protein kinase R pathway in cholangiocarcinoma. Oncogene 32, 3722-3731
92. Prasad, S., Sung, B., and Aggarwal, B. B. (2012) Age-associated chronic diseases require age-old medicine: role of chronic inflammation. Prev. Med. 54(Supp.), S29-S37
93. Couturier, J., Morel, M., Pontcharraud, R., Gontier, V., Fauconneau, B., Paccalin, M., and Page, G. (2010) Interaction of double-stranded RNA-dependent protein kinase (PKR) with the death receptor signaling pathway in amyloid beta (Abeta)-treated cells and in APPSLPS1 knock-in mice. J. Biol. Chem. 285, 1272-1282
94. Yarchoan, M., Louneva, N., Xie, S. X., Swenson, F. J., Hu, W., Soares, H., Trojanowski, J. Q., Lee, V. M., Kling, M. A., Shaw, L. M., Chen-Plotkin, A., Wolk, D. A., and Arnold, S. E. (2013) Association of plasma C-reactive protein levels with the diagnosis of Alzheimer's disease. J. Neurol. Sci. 333, 9-12
95. Paccalin, M., Pain-Barc, S., Pluchon, C., Paul, C., Besson, M. N., Carret-Rebillat, A. S., Rioux-Bilan, A., Gil, R., and Hugon, J. (2006) Activated mTOR and PKR kinases in lymphocytes correlate with memory and cognitive decline in Alzheimer's disease. Dement. Geriatr. Cogn. Disord. 22, 320-326
96. Mouton-Liger, F., Paquet, C., Dumurgier, J., Lapalus, P., Gray, F., Laplanche, J. L., and Hugon, J. (2012) Increased cerebrospinal fluid levels of double-stranded RNA-dependent protein kinase in Alzheimer's disease. Biol. Psychiatry 71, 829-835
97. Dumurgier, J., Mouton-Liger, F., Lapalus, P., Prevot, M., Laplanche, J. L., Hugon, J., and Paquet, C. (2013) Cerebrospinal fluid PKR level predicts cognitive decline in Alzheimer's disease. PLoS ONE 8, e53587
98. Lu, B., Nakamura, T., Inouye, K., Li, J., Tang, Y., Lundback, P., Valdes-Ferrer, S. I., Olofsson, P. S., Kalb, T., Roth, J., Zou, Y., Erlandsson-Harris, H., Yang, H., Ting, J. P., Wang, H., Andersson, U., Antoine, D. J., Chavan, S. S., Hotamisligil, G. S., and Tracey, K. J. (2012) Novel role of PKR in inflammasome activation and HMGB1 release. Nature 488, 670-674
99. He, Y., Franchi, L., and Nunez, G. (2013) The protein kinase PKR is critical for LPS-induced iNOS production but dispensable for inflammasome activation in macrophages. Eur. J. Immunol. 43, 1147-1152
100. Allen, I. C., TeKippe, E. M., Woodford, R. M., Uronis, J. M., Holl, E. K., Rogers, A. B., Herfarth, H. H., Jobin, C., and Ting, J. P. (2010) The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J. Exp. Med. 207, 1045-1056
101. Okamoto, M., Liu, W., Luo, Y., Tanaka, A., Cai, X., Norris, D. A., Dinarello, C. A., and Fujita, M. (2010) Constitutively active inflammasome in human melanoma cells mediating autoinflammation via caspase-1 processing and secretion of interleukin-1beta. J. Biol. Chem. 285, 6477-6488
102. Heneka, M. T., Kummer, M. P., Stutz, A., Delekate, A., Schwartz, S., Vieira-Saecker, A., Griep, A., Axt, D., Remus, A., Tzeng, T. C., Gelpi, E., Halle, A., Korte, M., Latz, E., and Golenbock, D. T. (2013) NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice. Nature 493, 674-678
103. Ito, T., Yang, M., and May, W. S. (1999) RAX, a cellular activator for double-stranded RNA-dependent protein kinase during stress signaling. J. Biol. Chem. 274, 15427-15432
104. Patel, R. C., and Sen, G. C. (1998) PACT, a protein activator of the interferon-induced protein kinase, PKR. EMBO J. 17, 4379-4390
105. Clerzius, G., Shaw, E., Daher, A., Burugu, S., Gelinas, J. F., Ear, T., Sinck, L., Routy, J. P., Mouland, A. J., Patel, R. C., and Gatignol, A. (2013) The PKR activator, PACT, becomes a PKR inhibitor during HIV-1 replication. Retrovirology 10, 96
106. Singh, M., Fowlkes, V., Handy, I., Patel, C. V., and Patel, R. C. (2009) Essential role of PACT-mediated PKR activation in tunicamycin-induced apoptosis. J. Mol. Biol. 385, 457-468
107. Peters, G. A., Seachrist, D. D., Keri, R. A., and Sen, G. C. (2009) The double-stranded RNA-binding protein, PACT, is required for postnatal anterior pituitary proliferation. Proc. Natl. Acad. Sci. U. S. A. 106, 10696-10701
108. Paquet, C., Mouton-Liger, F., Meurs, E. F., Mazot, P., Bouras, C., Pradier, L., Gray, F., and Hugon, J. (2012) The PKR activator PACT is induced by Abeta: involvement in Alzheimer's disease. Brain Pathol. 22, 219-229
109. Daniels, S. M., and Gatignol, A. (2012) The multiple functions of TRBP, at the hub of cell responses to viruses, stress, and cancer. Microbiol. Mol. Biol. Rev. 76, 652-666
110. Sanghvi, V. R., and Steel, L. F. (2011) The cellular TAR RNA binding protein, TRBP, promotes HIV-1 replication primarily by inhibiting the activation of double-stranded RNA-dependent kinase PKR. J. Virol. 85, 12614-12621
111. Singh, M., Castillo, D., Patel, C. V., and Patel, R. C. (2011) Stress-induced phosphorylation of PACT reduces its interaction with TRBP and leads to PKR activation. Biochemistry 50, 4550-4560
112. Ong, C. L., Thorpe, J. C., Gorry, P. R., Bannwarth, S., Jaworowski, A., Howard, J. L., Chung, S., Campbell, S., Christensen, H. S., Clerzius, G., Mouland, A. J., Gatignol, A., and Purcell, D. F. (2005) Low TRBP levels support an innate human immunodeficiency virus type 1 resistance in astrocytes by enhancing the PKR antiviral response. J. Virol. 79, 12763-12772
113. Bannwarth, S., Laine, S., Daher, A., Grandvaux, N., Clerzius, G., Leblanc, A. C., Hiscott, J., and Gatignol, A. (2006) Cellspecific regulation of TRBP1 promoter by NF-Y transcription factor in lymphocytes and astrocytes. J. Mol. Biol. 355, 898-910
114. Benkirane, M., Neuveut, C., Chun, R. F., Smith, S. M., Samuel, C. E., Gatignol, A., and Jeang, K. T. (1997) Oncogenic potential of TAR RNA binding protein TRBP and its regulatory interaction with RNA-dependent protein kinase PKR. EMBO J. 16, 611-624
115. Chan, C. T., Reeves, R. E., Geller, R., Yaghoubi, S. S., Hoehne, A., Solow-Cordero, D. E., Chiosis, G., Massoud, T. F., Paulmurugan, R., and Gambhir, S. S. (2012) Discovery and validation of small-molecule heat-shock protein 90 inhibitors through multimodality molecular imaging in living subjects. Proc. Natl. Acad. Sci. U. S. A. 109, E2476-E2485
116. Donze, O., Abbas-Terki, T., and Picard, D. (2001) The Hsp90 chaperone complex is both a facilitator and a repressor of the dsRNA-dependent kinase PKR. EMBO J. 20, 3771-3780
117. Zhao, M., Tang, D., Lechpammer, S., Hoffman, A., Asea, A., Stevenson, M. A., and Calderwood, S. K. (2002) Doublestranded RNA-dependent protein kinase (pkr) is essential for thermotolerance, accumulation of HSP70, and stabilization of ARE-containing HSP70 mRNA during stress. J. Biol. Chem. 277, 44539-44547
118. Pang, Q., Christianson, T. A., Keeble, W., Koretsky, T., and Bagby, G. C. (2002) The anti-apoptotic function of Hsp70 in the interferon-inducible double-stranded RNA-dependent protein kinase-mediated death signaling pathway requires the Fanconi anemia protein, FANCC. J. Biol. Chem. 277, 49638-49643
119. Pang, Q., Keeble, W., Christianson, T. A., Faulkner, G. R., and Bagby, G. C. (2001) FANCC interacts with Hsp70 to protect hematopoietic cells from IFN-gamma/TNF-alpha-mediated cytotoxicity. EMBO J. 20, 4478-4489
120. Fabbri, M., Ivan, M., Cimmino, A., Negrini, M., and Calin, G. A. (2007) Regulatory mechanisms of microRNAs involvement in cancer. Expert Opin. Biol. Ther. 7, 1009-1019
121. Saito, Y., and Saito, H. (2012) MicroRNAs in cancers and neurodegenerative disorders. Front. Genet. 3, 194
122. Lee, K., Kunkeaw, N., Jeon, S. H., Lee, I., Johnson, B. H., Kang, G. Y., Bang, J. Y., Park, H. S., Leelayuwat, C., and Lee, Y. S. (2011) Precursor miR-886, a novel noncoding RNA repressed in cancer, associates with PKR and modulates its activity. RNA 17, 1076-1089
123. Datta, B., Datta, R., Ghosh, A., and Majumdar, A. (2006) The binding between p67 and eukaryotic initiation factor 2 plays important roles in the protection of eIF2alpha from phosphorylation by kinases. Arch Biochem. Biophys 452, 138-148
124. Gil, J., Esteban, M., and Roth, D. (2000) In vivo regulation of the dsRNA-dependent protein kinase PKR by the cellular glycoprotein p67. Biochemistry 39, 16016-16025
125. Selvakumar, P., Lakshmikuttyamma, A., Lawman, Z., Bonham, K., Dimmock, J. R., and Sharma, R. K. (2004) Expression of methionine aminopeptidase 2, N-myristoyltransferase, and Nmyristoyltransferase inhibitor protein 71 in HT29. Biochem. Biophys. Res. Commun. 322, 1012-1017
126. Selvakumar, P., Lakshmikuttyamma, A., Kanthan, R., Kanthan, S. C., Dimmock, J. R., and Sharma, R. K. (2004) High expression of methionine aminopeptidase 2 in human colorectal adenocarcinomas. Clin. Cancer Res. 10, 2771-2775
127. Tucker, L. A., Zhang, Q., Sheppard, G. S., Lou, P., Jiang, F., McKeegan, E., Lesniewski, R., Davidsen, S. K., Bell, R. L., and Wang, J. (2008) Ectopic expression of methionine aminopeptidase-2 causes cell transformation and stimulates proliferation. Oncogene 27, 3967-3976
128. Rowlands, A. G., Panniers, R., and Henshaw, E. C. (1988) The catalytic mechanism of guanine nucleotide exchange factor action and competitive inhibition by phosphorylated eukaryotic initiation factor 2. J. Biol. Chem. 263, 5526-5533
129. Balachandran, S., and Barber, G. N. (2004) Defective translational control facilitates vesicular stomatitis virus oncolysis. Cancer Cell 5, 51-65
130. Blalock, W. L., Bavelloni, A., Piazzi, M., Tagliavini, F., Faenza, I., Martelli, A. M., Follo, M. Y., and Cocco, L. (2011) Multiple forms of PKR present in the nuclei of acute leukemia cells represent an active kinase that is responsive to stress. Leukemia 25, 236-245
131. Pang, Q., Christianson, T. A., Koretsky, T., Carlson, H., David, L., Keeble, W., Faulkner, G. R., Speckhart, A., and Bagby, G. C. (2003) Nucleophosmin interacts with and inhibits the catalytic function of eukaryotic initiation factor 2 kinase PKR. J. Biol. Chem. 278, 41709-41717
132. Garcia, M. A., Collado, M., Munoz-Fontela, C., Matheu, A., Marcos-Villar, L., Arroyo, J., Esteban, M., Serrano, M., and Rivas, C. (2006) Antiviral action of the tumor suppressor ARF. EMBO J. 25, 4284-4292
133. Romano, P. R., Garcia-Barrio, M. T., Zhang, X., Wang, Q., Taylor, D. R., Zhang, F., Herring, C., Mathews, M. B., Qin, J., and Hinnebusch, A. G. (1998) Autophosphorylation in the activation loop is required for full kinase activity in vivo of human and yeast eukaryotic initiation factor 2alpha kinases PKR and GCN2. Mol. Cell. Biol. 18, 2282-2297
134. Okumura, F., Okumura, A. J., Uematsu, K., Hatakeyama, S., Zhang, D. E., and Kamura, T. (2013) Activation of doublestranded RNA-activated protein kinase (PKR) by interferonstimulated gene 15 (ISG15) modification down-regulates protein translation. J. Biol. Chem. 288, 2839-2847
135. Zhao, C., Denison, C., Huibregtse, J. M., Gygi, S., and Krug, R. M. (2005) Human ISG15 conjugation targets both IFNinduced and constitutively expressed proteins functioning in diverse cellular pathways. Proc. Natl. Acad. Sci. U. S. A. 102, 10200-10205
136. Dey, M., Cao, C., Dar, A. C., Tamura, T., Ozato, K., Sicheri, F., and Dever, T. E. (2005) Mechanistic link between PKR dimerization, autophosphorylation, and eIF2alpha substrate recognition. Cell 122, 901-913
137. Yang, X. J., and Chiang, C. M. (2013) Sumoylation in gene regulation, human disease, and therapeutic action. F1000Prime Rep. 5, 45